- The study evaluated the performance of the Bioneer AccuPower® HIV-1 Quantitative RT-PCR kit by comparing it to the established Roche COBAS® AmpliPrep/COBAS® TaqMan® HIV-1 test using 288 plasma samples.
- Results showed a strong correlation between the two assays, with high agreement (94.9%) and a mean difference of only 0.11 Log10 IU/mL, indicating reliability in measurements.
- The findings suggest that the Bioneer assay is a viable option for quantifying HIV-1 RNA in clinical settings, supporting its use in therapeutic strategy development.